Evaluation of glial and neuronal blood biomarkers compared with clinical decision rules in assessing the need for computed tomography in patients with mild traumatic brain injury.

Evaluation of Glial and Neuronal Blood Biomarkers Compared With Clinical Decision Rules in Assessing the Need for Computed Tomography in Patients With Mild Traumatic Brain Injury – JAMA Network Open

Commentary on Twitter

In this prospective cohort of mTBI/concussion patients, CCHR, NOC and blood test GFAP/UCH-L1 were equally sensitive in detecting traumatic intracranial lesions on CT but CCHR had the highest specificity; GFAP combined with CCHR detected lesions best. https://t.co/hYwxg76uu8

— JAMA Network Open (@JAMANetworkOpen) March 14, 2022